Facebook
Facebook
Twitter
Twitter
LinkedIn
LinkedIn
Email
Email
0 Comments
Comments
The proliferation of generics to more than a 15 percent share and 25 percent annual growth is the major threat to branded drugs, and is an additional opportunity for package printers. New Year settlements of class-action lawsuits against the producers of pain relievers will include prescriptive consumer print media for Merck, Pfizer and others.
« Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 AllNext »
0 Comments
View Comments
- People:
- Vincent Mallardi
Related Content
Comments